(Q43136770)
Statements
1 reference
Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancers (English)
1 reference
Keith D Wilner
1 reference
Patricia M LoRusso
1 reference
Smitha S Krishnamurthi
1 reference
John J Rinehart
1 reference
Lisle M Nabell
1 reference
Lisa Malburg
1 reference
Paul B Chapman
1 reference
Samuel E DePrimo
1 reference
Steven Bentivegna
1 reference
Weiwei Tan
1 reference
Alejandro D Ricart
1 reference
9 March 2010
1 reference
1 reference
Identifiers
1 reference